It has been reported that increased circulating FABP4 levels are associated with obesity, insulin resistance, T2DM, hypertension, breast cancer independent of obesity, cardiac dysfunction, atherosclerosis, and metabolic syndrome [21,32,33,34,35,36]. Here, FABP4 is linked to type 2 diabetes mellitus.